Skip to main content
OpenTrials

Clinical trial condition

Stomach Neoplasms

Explore clinical trials studying Stomach Neoplasms. Study availability and eligibility vary by location and protocol.

1,998 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Stomach Neoplasms trial results

Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NCT06256328

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Matsuyama Red Cross Hospital Matsuyama, Ehime, Japan
  • NHO Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 63 locations
View Trial Details
Active, Not Recruiting

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

NCT07448493

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
Locations
  • Gomel Regional Clinical Oncology Dispensary (OKOD) Homyel, Belarus
  • Kaliningrad Regional Clinical Oncology Center Kaliningrad, Russia
  • Moscow Regional Oncology Hospital No. 62 Krasnogorsk, Russia
  • A.S. Loginov Moscow Clinical Scientific Center Moscow, Russia
View all 15 locations
View Trial Details
Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

NCT04868877

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +24 more
Locations
  • University of California, Irvine Orange, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
  • Next Oncology Virginia Fairfax, Virginia, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details

Related conditions